drugset / Trial / NCT00687180

Mycophenolate vs Azathioprin in Autoimmune Hepatitis

NCT00687180

Phase 4 Completed Rigshospitalet, Denmark
Treatment

Summary

A study with 20 de novo patients with autoimmune hepatitis, 10 receiving azathioprin and 10 receiving mycophenolat mofetil.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azathioprine Small molecule
Comparator Mycophenolate Mofetil Small molecule

Indications